ROYCE & ASSOCIATES LP - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 70 filers reported holding STEMLINE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 2.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$104,000
-1.9%
6,8000.0%0.00%0.0%
Q4 2017$106,000
-87.6%
6,800
-91.4%
0.00%
-83.3%
Q3 2016$852,000
-27.7%
78,679
-54.8%
0.01%
-25.0%
Q2 2016$1,179,000
+45.2%
174,1790.0%0.01%
+60.0%
Q1 2016$812,000
-19.1%
174,179
+9.4%
0.01%
-16.7%
Q4 2015$1,004,000
+198.8%
159,179
+318.9%
0.01%
+200.0%
Q3 2015$336,00038,0000.00%
Other shareholders

There were no reported owners of STEMLINE THERAPEUTICS INC in Q3 2016.

NameSharesValueWeighting ↓
View complete list of STEMLINE THERAPEUTICS INC shareholders